Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-04-09 Sale | 2026-04-10 4:52 pm | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan EVP, CFO & CBO | 8,224 | $89.84 | $738,844 | 71,776 (Direct) | View |
| 2026-03-31 Sale | 2026-04-01 5:26 pm | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan EVP, CFO & CBO | 114,367 | $83 | $9,492,596 | 90,399 (Direct) | View |
| 2025-12-04 Sale | 2025-12-05 8:00 pm | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 20,000 | $45.18 | $903,600 | 84,766 (Direct) | View |
| 2025-09-09 Sale | 2025-09-11 5:20 pm | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 20,000 | $35 | $700,000 | 104,766 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-04-09 Exercise | 2026-04-10 4:52 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan EVP, CFO & CBO | 8,224 | $17.88 | 71,776 (Direct) | View |
| 2026-04-09 Exercise | 2026-04-10 4:52 pm | N/A 2034-01-23 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan EVP, CFO & CBO | 8,224 | $0 | 71,776 (Direct) | View |
| 2026-03-31 Exercise | 2026-04-01 5:26 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan EVP, CFO & CBO | 74,367 | $8.44 | 90,399 (Direct) | View |
| 2026-03-31 Exercise | 2026-04-01 5:26 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan EVP, CFO & CBO | 40,000 | $17.88 | 90,399 (Direct) | View |
| 2026-03-31 Exercise | 2026-04-01 5:26 pm | N/A 2032-06-06 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan EVP, CFO & CBO | 114,367 | $0 | 90,399 (Direct) | View |
| 2026-02-03 Option Award | 2026-02-04 5:40 pm | N/A 2036-02-03 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan EVP, CFO & CBO | 150,000 | $0 | 150,000 (Direct) | View |
| 2025-12-04 Exercise | 2025-12-05 8:00 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 20,000 | $8.44 | 84,766 (Direct) | View |
| 2025-12-04 Exercise | 2025-12-05 8:00 pm | N/A 2032-06-06 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 20,000 | $0 | 84,766 (Direct) | View |
| 2025-09-23 Option Award | 2025-09-25 8:02 pm | N/A 2035-09-23 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 60,000 | $0 | 60,000 (Direct) | View |
| 2025-09-09 Exercise | 2025-09-11 5:20 pm | N/A N/A | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 20,000 | $8.44 | 104,766 (Direct) | View |
| 2025-09-09 Exercise | 2025-09-11 5:20 pm | N/A 2032-06-06 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 20,000 | $0 | 104,766 (Direct) | View |
| 2025-02-03 Option Award | 2025-02-04 4:18 pm | N/A 2035-02-02 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 150,000 | $0 | 150,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-28 8:04 pm | N/A 2034-05-22 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CFO & CBO | 100,000 | $0 | 100,000 (Direct) | View |
| 2024-01-24 Option Award | 2024-01-26 4:41 pm | N/A 2034-01-23 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CHIEF FINANCIAL OFFICER | 120,000 | $0 | 120,000 (Direct) | View |
Ownership | 2023-09-13 8:45 pm | N/A 2032-06-06 | Dianthus Therapeutics Inc. | DNTH | Savitz Ryan CHIEF FINANCIAL OFFICER | 0 | $0 | 124,766 (Direct) | View |